Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
- PMID: 27354955
- PMCID: PMC4910142
- DOI: 10.1016/j.rmcr.2016.05.008
Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
Abstract
Anti-melanoma differentiation-associated gene 5 (MDA5) antibodies are specific indicators of patients with dermatomyositis, particularly clinically amyopathic dermatomyositis (CADM). CADM is occasionally accompanied by fatal, treatment-resistant, rapidly-progressive interstitial lung disease (RP-ILD). All previous reports showed that histopathological findings in RP-ILD with anti-MDA5 antibody-positive CADM indicated diffuse alveolar damage (DAD). This is the first report describing a non-DAD pattern in RP-ILD with anti-MDA5 antibody-positive CADM, which was improved by immunosuppressive therapy. This case may be a milder clinical phenotype than a typical DAD pattern in RP-ILD with anti-MDA5 antibody-positive CADM.
Keywords: 6MWD, six-min walk distance; CADM; CADM, clinically amyopathic dermatomyositis; CT, computed tomography; DAD; DAD, diffuse alveolar damage; DLco, diffusing capacity of the lung for carbon monoxide; FVC, forced vital capacity; IVCY, intravenous cyclophosphamide; Lung histopathological pattern; MDA5; MDA5, melanoma differentiation-associated gene 5; MMRC, modified medical research council dyspnea scale; NSIP, nonspecific interstitial pneumonia; RP-ILD; RP-ILD, rapidly progressive interstitial lung disease.
Figures



References
-
- Koga T., Fujikawa K., Horai Y. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology. 2012;51:1278–1284. - PubMed
-
- Gono T., Kawaguchi Y., Satoh T. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology. 2010;49:1713–1719. - PubMed
-
- Muro Y., Sugiura K., Hoshino K., Akiyama M. Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM/interstitial lung disease during disease remission. Rheumatology. 2012;51:800–804. - PubMed
-
- Sato S., Kuwana M., Fujita T., Suzuki Y. Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod. Rheumatol. 2013;23:496–502. - PubMed
-
- Sontheimer R.D. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J. Am. Acad. Dermatol. 2002;46:626–636. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources